18 results
8-K
KRYS
Krystal Biotech Inc
26 May 22
Changes in Registrant's Certifying Accountant
4:34pm
. As a result of this process, effective May 24, 2022, the Audit Committee approved the engagement of KPMG LLP (“KPMG”) as the Company’s new independent … . In connection with the approval of the engagement of KPMG, management notified Mayer Hoffman that the auditor-client relationship would conclude immediately
8-K
EX-99.2
KRYS
Krystal Biotech Inc
29 Nov 21
Krystal Biotech Announces Positive Topline Results from GEM-3 Pivotal Trial of
4:06pm
engagement underway Exploring all access pathways in Europe No-charge genetic testing available to eligible US residents who are suspected of having EB … EB types and some non-EB genetic blistering conditions. Excellent EB community response to date Payer / Reimbursement Early engagement with US payer
8-K
EX-99.1
KRYS
Krystal Biotech Inc
28 Mar 22
Regulation FD Disclosure
4:06pm
Professional and Patient focused Disease State Awareness programming underway Medical Affairs Key Opinion Leader engagement underway Payer education … and engagement Initial Launch Focused on1,000 patients identified by claims database analytics Primarily treating more severe patients at Centers
8-K
EX-1.1
yqr5 obfnue6
21 May 20
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-1.1
2r99y6ltwkte
5 Feb 21
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-1.1
qmev y45gh
27 Jun 19
Entry into a Material Definitive Agreement
4:28pm
8-K
EX-1.1
j30e1sat
19 Oct 18
Krystal Biotech Announces Commencement of $60.0 Million Public Offering of Common Stock
5:27pm
8-K
EX-1.1
fbvdi
3 Dec 21
Entry into a Material Definitive Agreement
4:05pm
- Prev
- 1
- Next